CERRANO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1074
EU - Europa 607
AS - Asia 387
SA - Sud America 17
AF - Africa 12
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2111
Nazione #
US - Stati Uniti d'America 1062
CN - Cina 210
IT - Italia 189
IE - Irlanda 85
SE - Svezia 69
KR - Corea 63
DE - Germania 47
FR - Francia 42
VN - Vietnam 32
AT - Austria 24
ES - Italia 23
UA - Ucraina 23
IN - India 22
GB - Regno Unito 20
JP - Giappone 16
FI - Finlandia 13
TW - Taiwan 12
UZ - Uzbekistan 12
CA - Canada 11
CH - Svizzera 11
BR - Brasile 10
BY - Bielorussia 10
SN - Senegal 10
PL - Polonia 9
RU - Federazione Russa 9
NL - Olanda 7
PT - Portogallo 7
AU - Australia 6
CO - Colombia 5
BE - Belgio 4
EU - Europa 4
HK - Hong Kong 4
CZ - Repubblica Ceca 3
GR - Grecia 3
TR - Turchia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BN - Brunei Darussalam 2
DK - Danimarca 2
HU - Ungheria 2
ID - Indonesia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
SG - Singapore 2
TH - Thailandia 2
AR - Argentina 1
BO - Bolivia 1
LU - Lussemburgo 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
TN - Tunisia 1
Totale 2111
Città #
Chandler 197
Fairfield 113
Beijing 104
Dublin 84
Torino 59
Houston 58
Ashburn 46
Redwood City 46
Woodbridge 45
Cambridge 44
Medford 40
Wilmington 40
Nyköping 35
Ann Arbor 34
Seattle 32
Dong Ket 27
Princeton 24
Vienna 24
Villeurbanne 24
Jacksonville 23
Dearborn 16
Fremont 15
Hangzhou 14
Seoul 14
Turin 13
San Diego 11
Pisa 10
Taipei 9
Nanjing 8
Paris 7
Shanghai 7
São Paulo 7
Hefei 6
Milan 6
New York 6
San Mateo 6
Warsaw 6
Xian 6
Mountain View 5
Ottawa 5
Amsterdam 4
Bayreuth 4
Brussels 4
Chengdu 4
Hebei 4
Norwalk 4
Surbo 4
Tong 4
Toronto 4
Valencia 4
Villanova 4
Wuhan 4
Accord 3
Augusta 3
Basel 3
Bengaluru 3
Bogotá 3
Brno 3
Central District 3
Chennai 3
Chicago 3
Duncan 3
Freudenstadt 3
Guangzhou 3
Hyderabad 3
Kunming 3
Linda-a-velha 3
Lissone 3
Nanchang 3
Northampton 3
Palermo 3
Phoenix 3
Radomsko 3
Rochester 3
Sant Cugat Del Vallès 3
Tokyo 3
Zhengzhou 3
Absecon 2
Bologna 2
Boston 2
Collegeville 2
Düsseldorf 2
Faenza 2
Felgueiras 2
Florence 2
Guiyang 2
Hanoi 2
Istanbul 2
Madrid 2
Mortara 2
Munich 2
Málaga 2
Nancy 2
Regensburg 2
Rome 2
Salt Lake City 2
San Francisco 2
Sanford 2
Taizhou 2
Telford 2
Totale 1445
Nome #
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives 259
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation 210
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 173
Can pegylated interferon improve the outcome of polycythemia vera patients? 160
FLAI induction regimen in elderly patients with acute myeloid leukemia 155
Anemia in the Elderly: not Always what it Seems. 132
THE COMBINATION OF FLUDARABINE + CITARABINE + IDARUBICIN (FLAI) IS A SAFE AND EFFECTIVE TREATMENT FOR ELDERLY PATIENTS WITH AML OR HIGH RISK MDS 110
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice 100
TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS 86
IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE 77
Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications 77
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS 76
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience 64
Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm. 63
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET 62
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. 61
Biomarkers for acute and chronic graft versus host disease: state of the art 55
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia 49
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience 48
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation 48
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation 41
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience 41
null 37
Optimal delivery of follow-up care after allogeneic hematopoietic stem-cell transplant: Improving patient outcomes with a multidisciplinary approach 16
Totale 2200
Categoria #
all - tutte 3720
article - articoli 0
book - libri 0
conference - conferenze 823
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201881 0000 00 00 611910
2018/2019108 4232 60 217 3143718
2019/2020316 86727 1824 2835 81401725
2020/2021592 13514045 3729 5061 62427686
2021/2022468 27332956 3525 2721 16319573
2022/2023484 53641860 42130 3946 32000
Totale 2200